-

$undefined

N/A

(N/A)

Kairos Pharma :KAPA Kairos Pharma is focused on developing cutting-edge therapeutics for cancer patients that reverse the inhibitory effects of cancer on the immune system. By doing so, we seek to transform the way cancer is treated by positively impacting patient outcomes while maintaining quality of life.

Location: Los Angeles, California, United States | Website: https://kairospharma.com/ | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

13.24M

Cash

3.217M

Avg Qtr Burn

-521.5K

Short % of Float

8.69%

Insider Ownership

64.80%

Institutional Own.

2.97%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date